IPO NewsAnthem Biosciences Lists at 27% Premium Over IPO PriceEditor DeskJuly 21, 2025July 21, 2025 by Editor DeskJuly 21, 2025July 21, 202505 Anthem Biosciences Ltd. made a stellar debut in the secondary market with a premium of 27% over its IPO price. The scrip was listed at...
